Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.61 USD | -0.84% | -6.18% | -6.93% |
May. 09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
May. 09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 28K | Sales 2025 * | 29K | Capitalization | 212M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | -51M | EV / Sales 2024 * | 7,560 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 7,299 x |
P/E ratio 2024 * |
-3.98
x | P/E ratio 2025 * |
-4.19
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.84% |
Latest transcript on INmune Bio, Inc.
1 day | -0.84% | ||
1 week | -6.18% | ||
Current month | -11.49% | ||
1 month | +3.35% | ||
3 months | -18.89% | ||
6 months | +12.57% | ||
Current year | -6.93% |
Managers | Title | Age | Since |
---|---|---|---|
David Moss
FOU | Founder | 54 | 15-08-31 |
Mark Lowdell
FOU | Founder | 61 | 15-08-31 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcia Allen
BRD | Director/Board Member | 73 | 19-11-18 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Scott Juda
BRD | Director/Board Member | 53 | 18-03-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 10.48 | -2.06% | 12 885 |
24-05-22 | 10.7 | +1.33% | 60,090 |
24-05-21 | 10.56 | -5.97% | 96,919 |
24-05-20 | 11.23 | +3.50% | 122,662 |
24-05-17 | 10.85 | -2.86% | 84,727 |
Delayed Quote Nasdaq, May 23, 2024 at 10:02 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.93% | 212M | |
+10.26% | 115B | |
+12.28% | 106B | |
-6.01% | 24.69B | |
-1.11% | 21.97B | |
-4.83% | 19.27B | |
-12.03% | 17.56B | |
-39.36% | 17.32B | |
+5.56% | 14.03B | |
+33.15% | 12.13B |
- Stock Market
- Equities
- INMB Stock